NGS — Nutritional Growth Solutions Income Statement
0.000.00%
Last trade - 00:00- AU$4.93m
- AU$6.33m
- $2.48m
Annual income statement for Nutritional Growth Solutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.87 | 3.04 | 2.95 | 2.98 | 2.48 |
| Cost of Revenue | |||||
| Gross Profit | 0.92 | 1.36 | 1.44 | 0.842 | 0.811 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 4.12 | 7.77 | 7.29 | 6.05 | 5.31 |
| Operating Profit | -2.25 | -4.73 | -4.34 | -3.07 | -2.83 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -4.36 | -4.78 | -4.25 | -2.89 | -2.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.36 | -4.78 | -4.25 | -2.89 | -2.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.36 | -4.78 | -4.25 | -2.89 | -2.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.36 | -4.78 | -4.25 | -2.89 | -2.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.46 | -0.5 | -0.3 | -0.15 | -0.042 |